Cachexia Press Articles
Business Wire - GTx Announces Ostarine Increased Lean Body Mass and Leg Press Strength in Head to Head Clinical Study
Posted by admin / Under CachexiaJune 21, 2010 -- Ostarine, a SARM, built muscle mass and increased leg press strength in a clinical trial in postmenopausal women. SAN DIEGO -- GTx,...
Market Wire - Immunotec to Present at the World Cancer Congress Conference in Singapore
Posted by admin / Under CachexiaJune 16, 2010 -- Immunotec Inc. (TSX VENTURE: IMM), a Canadian based company and a leader in the wellness industry (the "Company"), today announced that Dr. Wulf...
Business Wire - GTx Presents Additional Study Results in Quality of Life Improvements from the Phase IIb Clinical Trial Evaluating Ostarine™ for Cancer Induced Muscle Wasting
Posted by admin / Under CachexiaJune 7, 2010 -- Data presented at ASCO show GTx's SARM Ostarine improved quality of life in patients with cancer cachexia (muscle wasting) who demonstrated an...
Market Wire - Galapagos initiates clinical studies with GLPG0492, a candidate drug for cachexia
Posted by admin / Under CachexiaMay 20, 2010 -- Galapagos NV (Euronext: GLPG) announced today that it has initiated a first-in-human trial for GLPG0492, its candidate drug for cachexia (loss...
Business Wire - GTx Announces Upcoming ASCO Presentations of Additional Study Results from Clinical Trials Evaluating Ostarine™ for Cancer Cachexia and Toremifene 80 mg for the Reduction of Fractures in Men with Prostate Cancer on ADT
Posted by admin / Under CachexiaMay 20, 2010 -- Ostarine Toremifene ASCO MEMPHIS, Tenn. -- GTx Inc. (Nasdaq: GTXI) today announced that additional study results from clinical...
